| Peter Zippelius |
Director |
$161M |
|
|
Oct 27, 2022 |
| Alessandro Maselli |
President & CEO, Director |
$10.4M |
-$534K |
-4.87% |
Jul 26, 2024 |
| John R. Chiminski |
Executive Chair, Director |
$8.55M |
|
|
Aug 24, 2022 |
| Aristippos Gennadios |
Group Pres. Pharma & Consumer |
$6.77M |
-$90.1K |
-1.31% |
Aug 2, 2024 |
| John J. Greisch |
Executive Chair, Director |
$6.69M |
|
|
Jul 26, 2024 |
| Matti Masanovich |
SVP, Chief Financial Officer |
$4.49M |
-$170K |
-3.64% |
Jul 26, 2024 |
| Steven L. Fasman |
EVP & Chief Admin Officer |
$2.69M |
|
|
Aug 23, 2023 |
| Donald E. Morel Jr |
Director |
$2.43M |
|
|
Oct 27, 2023 |
| Scott Gunther |
SVP, Quality & Reg. Affairs |
$2.36M |
-$78K |
-3.2% |
Aug 2, 2024 |
| Lisa Evoli |
SVP, Chief HR Officer |
$2.35M |
-$230K |
-8.93% |
Aug 2, 2024 |
| David McErlane |
Group President, Biologics |
$2.25M |
|
|
Jul 26, 2024 |
| Jonathan Arnold |
SVP, CCO & Div. Head BioP Del. |
$2.08M |
|
|
Aug 23, 2023 |
| Ricky Hopson |
Pres. BioProduct Delivery, CoS |
$1.79M |
-$128K |
-6.67% |
Aug 2, 2024 |
| Rolf A. Classon |
Director |
$1.61M |
|
|
Oct 27, 2023 |
| Jack L. Stahl |
Director |
$1.61M |
|
|
Oct 27, 2023 |
| Joseph Anthony Ferraro |
SVP, General Counsel, CCO |
$1.45M |
-$36.2K |
-2.44% |
Aug 2, 2024 |
| Gregory T. Lucier |
Director |
$1.2M |
|
|
Oct 27, 2023 |
| Ricardo Pravda |
Chief Transformation Officer |
$1.1M |
|
|
Aug 23, 2023 |
| J. Martin Carroll |
Director |
$1.04M |
|
|
Oct 27, 2023 |
| Madhavan Balachandran |
Director |
$1.02M |
|
|
Oct 27, 2023 |
| Christa Kreuzburg |
Director |
$922K |
|
|
Jan 25, 2024 |
| Karen Flynn |
Director |
$905K |
|
|
Oct 27, 2023 |
| Rosemary A. Crane |
Director |
$888K |
|
|
Oct 27, 2023 |
| Michael J. Grippo |
SVP, Strategy & Corp. Dev. |
$882K |
|
|
Aug 23, 2023 |
| Michael Hatzfeld |
Chief Accounting Officer |
$795K |
|
|
Jul 26, 2024 |
| Thomas P. Castellano |
SVP, Chief Financial Officer |
$747K |
|
|
Aug 24, 2022 |
| Kay A. Schmidt |
SVP, Enterprise Functions |
$646K |
|
|
Aug 24, 2022 |
| Manja Boerman |
Pres. BioModalities Division |
$536K |
|
|
May 1, 2023 |
| Michael Barber |
Director |
$498K |
|
|
Oct 27, 2023 |
| Patricia Hunt |
Pres. Consumer Health Div |
$419K |
|
|
Oct 16, 2023 |
| Charles Lickfold |
Svp, Cio |
$405K |
|
|
Aug 23, 2023 |
| Michelle R. Ryan |
Director |
$334K |
|
|
Oct 27, 2023 |
| Lorenzo Carletti |
SVP Global Ops Ph & Cons Hlth |
$316K |
|
|
Aug 23, 2023 |
| Stephanie Okey |
Director |
$296K |
|
|
Oct 27, 2023 |
| Frank A. Damelio |
Director |
$296K |
|
|
Oct 27, 2023 |
| Steven Barg |
Director |
$287K |
|
|
Oct 27, 2023 |
| Thomas W. Hawkeswood |
Pres. Pharma Prod Delivery Div |
$276K |
|
|
Aug 23, 2023 |
| Michael A. Riley |
Pres. Bio Product Delivery Div |
$245K |
|
|
Aug 26, 2022 |
| Ricardo Zayas |
SVP, Operations, Biologics NA |
$231K |
|
|
Aug 1, 2023 |
| Mario Gargiulo |
SVP, Ops, Biologics Europe |
$211K |
|
|
May 1, 2023 |
| Karen Murphy Santiago |
VP & Chief Accounting Officer |
$177K |
|
|
Aug 1, 2023 |
| Ricci Whitlow |
President, CSS |
$109K |
|
|
Jan 21, 2022 |